This program is provided by Oakstone Publishing, LLC.
This program is produced by Oakstone Publishing, LLC.
Led by Program Directors, Joseph S. Sanfilippo, MD and Eric Bieber, MD, the talented and renowned faculty of the OB/GYN: A Comprehensive Review will help you to better:
Understand obstetric topics such as preconception and prenatal care, medications, diabetes and infections during pregnancy, preterm birth, multiple pregnancy, fetal surveillance, preeclampsia, and prevention of a C-section
Tap expert knowledge in gynecology with presentations on topics such as: adnexal masses, abnormal uterine bleeding, pelvic pain, genital tract infections, amenorrhea, menopause, cervical cancer, infertility, contraception, endometriosis, and gyn infections
The target audience for the program is practicing obstetricians and gynecologists, residents and fellows. The program is focused on closing professional practice gaps in patient care provided by obstetricians and gynecologists through the increased adoption of best practice standards.
As an example, for the lecture on cervical cancer screening, a gap is the overscreening of women less than 21 years of age, whereas national guidelines since 2009 have recommended initiation of screening at age 21 years. Further, the most recent guidelines recommended a screening interval with cytology alone every 3 years for women ages 21-29 and screening with cytology and HPV every 5 years for women 30 years of age and greater. By overscreening young women, unnecessary testing and treatment often ensues, creating increased patient risk and harm, as well as increased health care costs.
Upon completion of the lecture(s) and case(s) on cervical cancer screening, the participant will:
Describe the appropriate cervical cancer screening test and interval based upon patient age
Discuss follow-up testing and surveillance for abnormal screening results
Apply the most recent updated national cervical cancer screening guidelines to annual well-women visits
Topics and Speakers
Click here for a complete list of course topics and speakers.
Conflict Of Interest Disclosure Policy
It is the policy of Oakstone Publishing, LLC that the faculty and provider disclose real or apparent conflict of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Oakstone has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
Program Directors Joseph S. Sanfilippo, MD, MBA University of Pittsburgh School of Medicine Professor Obstetrics, Gynecology & Reproductive Sciences Magee-Women's Hospital Advisory Role: Bayer Healthcare/Smith-nephew
Eric J. Bieber, MD, MSHCM President, Community Hospitals - West Region President, UH Accountable Care Organization Clinical Professor of Reproductive Biology CWRU School of Medicine Reports no commercial interest
Speakers Andrew Kaunitz, MD, FACOG Professor and Associate Chair Department of Obstetrics and Gynecology University of Florida College of Medicine-Jacksonville Research Grants: Agile, Bayer, Noven, Teva, Trimel, TherpeuticsMD Advisory Role: Actavis, Bayer, Merck, Teva Board Membership: North AMerican Menopause Society Honoraria: Royalties: UpToDate
William Kutteh, MD, PhD, HCLD Clinical Professor, Obstetrics and Gynecology Division of Reproductive Endocrinology Vanderbilt University Medical Center Consulting Gynecologist St. Jude Children's Hospital Director, Center for the Study of Recurrent Pregnancy Loss Fertility Associates of Memphis Reports no commercial interest
Malcolm Munro, MD, FRCS(c), FACOG, FRCSC Professor Department of Obstetrics and Gynecology David Geffen School of Medicine at UCLA Director of Gynecologic Services Reports commercial interest with Aegea Medical, Bayer, Boston Scientific, Channel Medical, Gynesonics inc, halt medical, idoman teoranta, karl storz endoscopy, vifor
Charles E. Miller, MD Current Founder President and Medical Director Charles E. Miller, MD & Associates Specialists in Reproductive Health Arlington Heights and Naperville, Illinois Research Grants: Covidien, Femasys, Olympus, Novartis, Abbvie, Intuitive Surgical Advisory Role: Ferring Pharmaceuticals, Ethicon, Boston Scientific, Care Fusion, Hologic, Covidien, Femasys, Abbvie, Halt Medical, Intuitive Surgical, OmniGuide
Jacques Abramowicz, MD, FACOG, FAIUM Professor of Ob/Gyn Director of Ob/Gyn Ultrasound Services Director of Reproductive Genetics Wayne State University School of Medicine Baha Sibai, MD Visiting Professor UT Health Reports no commercial interest
Amy Whitaker, MD, MS Assistant Professor University of Chicago Pritzker School of Medicine Department of Obstetrics and Gynecology Section of Family Planning and Contraceptive Research Reports no commercial interest
Lee P. Shulman MD The Anna Ross Lapham Professor in Obstetrics and Gynecology and Chief Division of Clinical Genetics Director, Northwestern Ovarian Cancer Early Detection and Prevention Program Northwestern University The Feinberg School of Medicine Advisory Role: Bayer, Merck, Shionogi, Watson, Sequenom, natera, Vermillion, Roche
Resad Pasic, MD, PhD Professor Department of Obstetrics Gynecology Women's Heath, University of Louisville School of Medicine Director Division of MIGS Director Fellowship in MIGS Research Grants: Ethicon Endo, Karl Storz Advisory Role: Cooper Surgical, Ethicon Endo, karl Storz
Eva Chalas, MD, FACOG, FACS Director of Clinical Cancer Services Vice-Chair, Department of Obstetrics and Gynecology Chief, Division of Gynecologic Oncology Winthrop University Hospital Professor, Stony Brook University Medical Center Reports no commercial interest
Joshua P. Kesterson, MD Assistant Professor Milton S. Hershey Medical Center Pennsylvania State University College of Medicine Department of Obstetrics and Gynecology Division of Gynecologic Oncology Reports no commercial interest
Vincenzo Berghella, MD Professor, Obstetrics & Gynecology Director, Maternal-Fetal Medicine Jefferson Medical College of Thomas Jefferson University Reports no commercial interest
Murray Freedman, MD Clinical Professor Obstetrics and Gynecology Medical College of Georgia at Georgia Regents' University Research Grants: Procter & Gamble Advisory Role: Shionogi, Board Membership: Shionogi Honoraria: Shionogi
Sylvia Botros, MD Clinical Assistant Professor, North Shore Medical Group Program Director, Female Pelvic Medicine University of Chicago Pritzker School of Medicine Reports no commercial interest
Mark Pearlman, MD S Jan Behrman Professor Vice Chair and Service Chief Obstetrics & Gynecology Director, Fellowship in Breast Diseases in Ob/Gyn University of Michigan Health System Reports no commercial interest
Sabrina Holmquist, MD, MPH Associate Professor of Obstetrics/Gynecology University of Chicago Pritzker School of Medicine Reports no commercial interest
Adam J. Duhl, MD Associate Professor of OB/GYN The Commonwealth Medical College Reports no commercial interest
Serdar Ural, MD, FACOG Professor Obstetrics and Gynecology Pennsylvania State University College of Medicine Reports no commercial interest
Mary Ellen Pavone, MD MSCI Assistant Professor Medical Director, IVF Department of Obstetrics and Gynecology Division of Reproductive Endocrinology and Infertility Northwestern University The Feinberg School of Medicine Reports no commercial interest
James M. Palmer, MD, MS Residency Program Director Department of Obstetrics and Gynecology University of South Florida Health Morsani College of Medicine Reports no commercial interest
John Lurain, MD Director, John I. Brewer Trophoblastic Disease Center Program Director for the Fellowship in Gynecologic Oncology Northwestern Memorial Hospital Reports no commercial interest
Alfred Guirguis, DO Assistant Professor Gynecologic Oncology Obstetrics and Gynecology Rush University Medical Center Reports no commercial interest
Nicole M. Donnellan, MD Assistant Professor Department of Obstetrics, Gynecology and Reproductive Sciences Magee-Women's Hospital University of Pittsburgh Medical Center Reports no commercial interest
Publishing Staff Disclosures
Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors, and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing’s planners, content reviewers, and editorial staff disclose no relevant commercial interests.
Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Oakstone Publishing, LLC designates this enduring material for a maximum of 31.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The opinions and recommendations expressed by the faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Oakstone Publishing, LLC name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
METHOD OF PARTICIPATION: Once logged into the website, review the audio/videos, complete the comprehensive activity evaluation and score 70% or greater on the required post-test to assess the knowledge gained from reviewing the program. Once the activity and evaluation are complete and a satisfactory score is earned on the post test, you can print your CME certificate located under the certificate tab.
If you have any questions relating to the accreditation of this activity, please contact email@example.com.
Due to the nature of Oakstone’s product, its audio/video format and educational content, no refunds are permitted. You may return the product within 15 days of receipt and receive a credit reflective of the original price you paid for the item. This credit may be applied as payment to any product(s) produced by Oakstone Publishing, LLC. We guarantee your program against defects in materials. Simply return any defective materials, and we will replace them. To make a return, call 800-633-4743 for a Return Authorization Code. Complete the packing ticket and return with the program to 2700 Corporate Drive, Suite 100, Birmingham, AL 35242. We recommend shipping through UPS or FedEx. Return shipping fees are the responsibility of the purchaser.
ONLINE STREAMING Windows XP, Vista, 7 or 8 on Pc and Macintosh OS X or above on Mac computers with most current Flash player/Quicktime software and latest version of web browsers (Internet Explorer 7 or higher, Firefox 2.0 or higher, Safari 5 or higher and Chrome) for each.